NEWS

Suite success for Dotmatics

Dotmatics, a provider of informatics solutions to the pharmaceutical and biotechnology industries, has announced that The Moulder Centre for Drug Discovery Research at Temple University, Philidelphia, has licensed the Dotmatics suite of solutions to boost its drug discovery research.

The Dotmatics platform is an integrated suite of software specifically designed to maximise efficiency in data transfer between research institutes, collaborators and CROs.

'After a thorough review of the commercially available software packages for sharing and exploiting the fruits of drug discovery research, it became clear that the Dotmatics platform represented not only the best configuration, but also the most comprehensive package available,' said Magid Abou-Gharbia, associate dean for research and director of the Moulder Center.

'In building our capacity we are focused on efficiently generating research data using a host of technologies and tools. The combination of Browser, Vortex and StudiesNotebook are key solutions that will allow our scientists to quickly triage, integrate and analyse data from multiple sources, speeding the pace and efficiency of research.'

Twitter icon
Google icon
Del.icio.us icon
Digg icon
LinkedIn icon
Reddit icon
e-mail icon
Feature

Gemma Church finds out how astronomers are using simulations to investigate the extremities of our universe

Feature

Turning data into scientific insight is not a straightforward matter, writes Sophia Ktori

Feature

The Leibniz Supercomputing Centre (LRZ) is driving the development of new energy-efficient practices for HPC, as Robert Roe discovers

Feature

William Payne investigates the growing trend of using modular HPC, built on industry standard hardware and software, to support users across a range of both existing and emerging application areas

Feature

Robert Roe looks at developments in crash testing simulation – including larger, more intricate simulations, the use of optimisation software, and the development of new methodologies through collaboration between ISVs, commercial companies, and research organisations